Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD)

No evidence for association in the Irish population

Z. Hawi, D. Foley, A. Kirley, M. McCarron, M. Fitzgerald, M. Gill

Research output: Contribution to journalArticleResearchpeer-review

34 Citations (Scopus)

Abstract

Dopa decarboxylase (DDC) is an enzyme which catalyses the decarboxylation of both dopa to dopamine and L-5 hydroxytryptophan to serotonin. Both catecholamines are major neurotransmitters of the mammalian nervous system. It has been suggested that genes involved in the dopaminergic system play a primary role in predisposing to attention deficit hyperactivity disorder (ADHD). In this study, the 4-bp insertion/deletion variant mapped to the first neuronally expressed exon 1 at the dopa decarboxylase gene and two microsatellite markers flanking the gene were investigated for possible association with ADHD. Using HHRR, we observed an increased transmission (though not significant) of the 4-bp insertion (allele 1) to ADHD cases (X2 = 2.72, P = 0.1, RR = 1.25). However marginally significant excess transmission of allele 10 (213 bp) of the 3′ microsatellite D7S2422 (∼0.75 cM distal to dopa decarboxylase gene) was found (X2 = 4.2, P = 0.04, RR=1.48). Interestingly, a haplotype containing both alleles is transmitted more frequently (X2 = 5, P = 0.025). Analysing data by the sex of transmitting parent showed a greater relative risk for paternal transmission of the 4-bp insertion allele and allele 10 of the D7S2422 (RR = 1.48 and 1.63 respectively). This provides preliminary evidence that this locus or a closely mapped DNA variant may be involved in the genetic susceptibility to ADHD. However, further studies are required to either confirm or refute these observations.

Original languageEnglish
Pages (from-to)420-424
Number of pages5
JournalMolecular Psychiatry
Volume6
Issue number4
DOIs
Publication statusPublished - 2001
Externally publishedYes

Keywords

  • Association
  • Attention deficit hyperactivity disorder (ADHD)
  • Dopa decarboxylase
  • Dopamine
  • Haplotype based haplotype relative risk (HHRR)

Cite this

@article{c270c9c102b84332972d59648a4bbf90,
title = "Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): No evidence for association in the Irish population",
abstract = "Dopa decarboxylase (DDC) is an enzyme which catalyses the decarboxylation of both dopa to dopamine and L-5 hydroxytryptophan to serotonin. Both catecholamines are major neurotransmitters of the mammalian nervous system. It has been suggested that genes involved in the dopaminergic system play a primary role in predisposing to attention deficit hyperactivity disorder (ADHD). In this study, the 4-bp insertion/deletion variant mapped to the first neuronally expressed exon 1 at the dopa decarboxylase gene and two microsatellite markers flanking the gene were investigated for possible association with ADHD. Using HHRR, we observed an increased transmission (though not significant) of the 4-bp insertion (allele 1) to ADHD cases (X2 = 2.72, P = 0.1, RR = 1.25). However marginally significant excess transmission of allele 10 (213 bp) of the 3′ microsatellite D7S2422 (∼0.75 cM distal to dopa decarboxylase gene) was found (X2 = 4.2, P = 0.04, RR=1.48). Interestingly, a haplotype containing both alleles is transmitted more frequently (X2 = 5, P = 0.025). Analysing data by the sex of transmitting parent showed a greater relative risk for paternal transmission of the 4-bp insertion allele and allele 10 of the D7S2422 (RR = 1.48 and 1.63 respectively). This provides preliminary evidence that this locus or a closely mapped DNA variant may be involved in the genetic susceptibility to ADHD. However, further studies are required to either confirm or refute these observations.",
keywords = "Association, Attention deficit hyperactivity disorder (ADHD), Dopa decarboxylase, Dopamine, Haplotype based haplotype relative risk (HHRR)",
author = "Z. Hawi and D. Foley and A. Kirley and M. McCarron and M. Fitzgerald and M. Gill",
year = "2001",
doi = "10.1038/sj.mp.4000903",
language = "English",
volume = "6",
pages = "420--424",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "4",

}

Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD) : No evidence for association in the Irish population. / Hawi, Z.; Foley, D.; Kirley, A.; McCarron, M.; Fitzgerald, M.; Gill, M.

In: Molecular Psychiatry, Vol. 6, No. 4, 2001, p. 420-424.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD)

T2 - No evidence for association in the Irish population

AU - Hawi, Z.

AU - Foley, D.

AU - Kirley, A.

AU - McCarron, M.

AU - Fitzgerald, M.

AU - Gill, M.

PY - 2001

Y1 - 2001

N2 - Dopa decarboxylase (DDC) is an enzyme which catalyses the decarboxylation of both dopa to dopamine and L-5 hydroxytryptophan to serotonin. Both catecholamines are major neurotransmitters of the mammalian nervous system. It has been suggested that genes involved in the dopaminergic system play a primary role in predisposing to attention deficit hyperactivity disorder (ADHD). In this study, the 4-bp insertion/deletion variant mapped to the first neuronally expressed exon 1 at the dopa decarboxylase gene and two microsatellite markers flanking the gene were investigated for possible association with ADHD. Using HHRR, we observed an increased transmission (though not significant) of the 4-bp insertion (allele 1) to ADHD cases (X2 = 2.72, P = 0.1, RR = 1.25). However marginally significant excess transmission of allele 10 (213 bp) of the 3′ microsatellite D7S2422 (∼0.75 cM distal to dopa decarboxylase gene) was found (X2 = 4.2, P = 0.04, RR=1.48). Interestingly, a haplotype containing both alleles is transmitted more frequently (X2 = 5, P = 0.025). Analysing data by the sex of transmitting parent showed a greater relative risk for paternal transmission of the 4-bp insertion allele and allele 10 of the D7S2422 (RR = 1.48 and 1.63 respectively). This provides preliminary evidence that this locus or a closely mapped DNA variant may be involved in the genetic susceptibility to ADHD. However, further studies are required to either confirm or refute these observations.

AB - Dopa decarboxylase (DDC) is an enzyme which catalyses the decarboxylation of both dopa to dopamine and L-5 hydroxytryptophan to serotonin. Both catecholamines are major neurotransmitters of the mammalian nervous system. It has been suggested that genes involved in the dopaminergic system play a primary role in predisposing to attention deficit hyperactivity disorder (ADHD). In this study, the 4-bp insertion/deletion variant mapped to the first neuronally expressed exon 1 at the dopa decarboxylase gene and two microsatellite markers flanking the gene were investigated for possible association with ADHD. Using HHRR, we observed an increased transmission (though not significant) of the 4-bp insertion (allele 1) to ADHD cases (X2 = 2.72, P = 0.1, RR = 1.25). However marginally significant excess transmission of allele 10 (213 bp) of the 3′ microsatellite D7S2422 (∼0.75 cM distal to dopa decarboxylase gene) was found (X2 = 4.2, P = 0.04, RR=1.48). Interestingly, a haplotype containing both alleles is transmitted more frequently (X2 = 5, P = 0.025). Analysing data by the sex of transmitting parent showed a greater relative risk for paternal transmission of the 4-bp insertion allele and allele 10 of the D7S2422 (RR = 1.48 and 1.63 respectively). This provides preliminary evidence that this locus or a closely mapped DNA variant may be involved in the genetic susceptibility to ADHD. However, further studies are required to either confirm or refute these observations.

KW - Association

KW - Attention deficit hyperactivity disorder (ADHD)

KW - Dopa decarboxylase

KW - Dopamine

KW - Haplotype based haplotype relative risk (HHRR)

UR - http://www.scopus.com/inward/record.url?scp=0034989797&partnerID=8YFLogxK

U2 - 10.1038/sj.mp.4000903

DO - 10.1038/sj.mp.4000903

M3 - Article

VL - 6

SP - 420

EP - 424

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 4

ER -